Psoriatic Arthritis Treatment Market Size, Share & Trends Analysis Report By Drug Type (NSAIDs, DMARDs, Biologics, Others), By Type (Prescription, OTC), By Route of Administration (Injectable, Oral, Topical) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR5238DR | Pages: 110

Market Segmentation

  1. Psoriatic Arthritis Treatment Market, By Drug Type 2022-2034 (USD MILLION/ Units)
    1. NSAIDs
    2. DMARDs
    3. Biologics
    4. Others
  2. Psoriatic Arthritis Treatment Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Prescription
    2. OTC
  3. Psoriatic Arthritis Treatment Market, By Route of Administration 2022-2034 (USD MILLION/ Units)
    1. Injectable
    2. Oral
    3. Topical
  4. Regional Psoriatic Arthritis Treatment Market
    1. North America
      1. North America Psoriatic Arthritis Treatment Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
      2. North America Psoriatic Arthritis Treatment Market By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. OTC
      3. North America Psoriatic Arthritis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Injectable
        2. Oral
        3. Topical
      4. U.S.
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
      5. Canada
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
    2. Europe
      1. Europe Psoriatic Arthritis Treatment Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
      2. Europe Psoriatic Arthritis Treatment Market By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. OTC
      3. Europe Psoriatic Arthritis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Injectable
        2. Oral
        3. Topical
      4. U.K.
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
      5. Germany
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
      6. France
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
      7. Spain
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
      8. Italy
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
      9. Russia
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
      10. Nordic
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
      11. Benelux
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
      12. Rest of Europe
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
    3. APAC
      1. APAC Psoriatic Arthritis Treatment Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
      2. APAC Psoriatic Arthritis Treatment Market By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. OTC
      3. APAC Psoriatic Arthritis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Injectable
        2. Oral
        3. Topical
      4. China
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
      5. Korea
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
      6. Japan
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
      7. India
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
      8. Australia
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
      9. Singapore
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
      10. Taiwan
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
      11. South East Asia
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
      12. Rest of Asia-Pacific
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
    4. Middle East and Africa
      1. Middle East and Africa Psoriatic Arthritis Treatment Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
      2. Middle East and Africa Psoriatic Arthritis Treatment Market By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. OTC
      3. Middle East and Africa Psoriatic Arthritis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Injectable
        2. Oral
        3. Topical
      4. UAE
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
      5. Turkey
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
      6. Saudi Arabia
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
      7. South Africa
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
      8. Egypt
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
      9. Nigeria
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
      10. Rest of MEA
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
    5. LATAM
      1. LATAM Psoriatic Arthritis Treatment Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
      2. LATAM Psoriatic Arthritis Treatment Market By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. OTC
      3. LATAM Psoriatic Arthritis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Injectable
        2. Oral
        3. Topical
      4. Brazil
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
      5. Mexico
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
      6. Argentina
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
      7. Chile
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
      8. Colombia
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
      9. Rest of LATAM
        1. NSAIDs
        2. DMARDs
        3. Biologics
        4. Others
        5. Prescription
        6. OTC
        7. Injectable
        8. Oral
        9. Topical
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on: